12 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
, and requires manufacturers to provide discounts on Part D drugs. Substantial penalties can be assessed for noncompliance with the drug pricing provisions … , 2022, President Biden signed the Inflation Reduction Act of 2022 into law. This legislation contains substantial drug pricing reforms, including
DRS
CGTX
Cognition Therapeutics Inc
20 Oct 22
Draft registration statement
12:00am
three to five years. The Inflation Reduction Act of 2022 contains substantial drug pricing reforms, including the establishment of a drug price … . Substantial penalties can be assessed for noncompliance with the drug pricing provisions in the Inflation Reduction Act of 2022. The Inflation
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
and ongoing ballot initiatives that create additional pressure on drug pricing and may affect how pharmaceutical products are covered and reimbursed. A number
424B4
v4ru jp4k
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
i60loyuxow8
19 Jul 21
IPO registration
7:02am
DRS/A
4yq9hx 37v60
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
gqqbg3adh7egxd6
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next